Direct Answer
Charles River Laboratories reported revenue of $4.0 billion for the fiscal year ended December 27, 2025, with an operating margin of 0.6% and net income of -$144 million, according to its SEC filings. Revenue fell 0.9% from the prior year.
What Are Charles River Laboratories's Key Financial Figures?
| Fiscal year | FY2025 ended December 27, 2025 | FY2024 ended December 28, 2024 | FY2023 ended December 30, 2023 | FY2022 ended December 31, 2022 |
|---|---|---|---|---|
| Revenue | $4.0 billion | $4.0 billion | $4.1 billion | $4.0 billion |
| Operating income | $25 million | $227 million | $617 million | $651 million |
| Operating margin | 0.6% | 5.6% | 14.9% | 16.4% |
| Net income | -$144 million | $22 million | $475 million | $486 million |
| Net margin | -3.6% | 0.5% | 11.5% | 12.2% |
| Operating cash flow | $738 million | $735 million | $684 million | $620 million |
| Capital expenditures | $219 million | $233 million | $319 million | $325 million |
| Free cash flow | $518 million | $502 million | $365 million | $295 million |
Operating margin narrowed by 5.0 percentage points between fiscal 2024 and 2025, which separates pricing and cost discipline from revenue growth alone. Free cash flow (operating cash flow minus capital expenditures) was $518 million against net income of -$144 million; cash generation covered reported earnings.
What Does Charles River Laboratories's Balance Sheet Show?
| Cash and cash equivalents | $214 million |
|---|---|
| Long-term debt | $2.1 billion |
| Total assets | $7.1 billion |
| Total liabilities | $3.9 billion |
| Shareholders' equity | $3.2 billion |
| Current ratio | 1.3x |
Balance sheet values are as of the end of fiscal 2025. Income statement figures describe a whole year; balance sheet figures describe a single day, so the two answer different questions.
Where These Numbers Come From
Every figure on this page is a value Charles River Laboratories reported in its own SEC filings, read from the SEC's XBRL data (accession 0001100682-26-000022 for fiscal year 2025). Ratios are computed from those reported values. Figures were retrieved on October 12, 2026; a later amendment or a new annual report can change them, and the filing itself always takes precedence over this summary.
Each fiscal year is labeled by the calendar year in which it ended, so a company that names the same period differently in its own filings (many retailers whose year ends in January) may use another label. A year is left out of the table when the SEC data set holds no value for it. A figure shown as "Not reported" means the company did not file a value under the standard tag Swoopr reads, not that the amount was zero. This page is educational and describes reported history only; it is not a forecast or a recommendation.
Frequently Asked Questions
What was Charles River Laboratories's revenue in fiscal 2025?
Charles River Laboratories reported revenue of $4.0 billion for the fiscal year ended December 27, 2025, according to its SEC filings.
What is Charles River Laboratories's operating margin?
Charles River Laboratories's operating margin was 0.6% in fiscal 2025: operating income of $25 million on revenue of $4.0 billion.
How much free cash flow did Charles River Laboratories generate?
Operating cash flow of $738 million less capital expenditures of $219 million gives free cash flow of $518 million for fiscal 2025.